To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Hematopoietic stem cell
Hematopoietic stem cells (HSC) are stem cells which give rise to all the blood cell types including myeloid (monocytes and macrophages, neutrophils, basophils, eosinophils, erythrocytes, megakaryocytes/platelets, dendritic cells) and lymphoid lineages (T-cells, B-cells, NK-cells). The definition of hematopoietic stem cells has undergone considerable revision in the last two decades. The hematopoietic tissue contains cells with long term and short term regeneration capacities and committed multipotent, oligopotent and unipotent progenitors. Recently, long-term transplantation experiments point towards a clonal diversity model of hematopoietic stem cells. Here, the HSC compartment consists of a fixed number of different types of HSC, each with epigenetically preprogrammed behavior. This contradicts older models of HSC behavior, which postulated a single type of HSC that can be continuously molded into different subtypes of HSC.
HSC are found in the bone marrow of adults, which includes femurs, hip, ribs, sternum, and other bones. Cells can be obtained directly by removal from the hip using a needle and syringe, or from the blood following pre-treatment with cytokines, such as G-CSF (granulocyte colony stimulating factors), that induce cells to be released from the bone marrow compartment. Other sources for clinical and scientific use include umbilical cord blood, placenta, molilized peripheral blood. For experimental purposes, fetal liver, fetal spleen and AGM (Aorta-gonad-mesonephros) of animals are also useful sources of HSCs.
Multipotency and self-renewal
As stem cells, they are defined by their ability to form multiple cell types (multipotency) and their ability to self-renew.
It is known that a small number of HSC can expand to generate a very large number of progeny HSC. This phenomenon is used in bone marrow transplant when a small number of HSC reconstitute the hematopoietic system. This indicates that at least during bone marrow transplant, symmetrical cell divisions that give two progeny HSC must occur, as expansion in HSC numbers seen during bone marrow transplant cannot occur in any other way.
Stem cell self-renewal is thought to occur in the stem cell niche in the bone marrow, and it is reasonable to assume that key signals present in this niche will be important in self-renewal. There is much interest in the environmental and molecular requirements for HSC self-renewal, as understanding the ability of HSC to replenish themselves will eventually allow the generation of expanded populations of HSC ex vivo that can be used therapeutically.
Using limiting dilution strategies combined with other streamlined experimental and statistical methods for examining HSC at the clonal level, it was shown that HSC fall into three distinct clusters. These are quantitatively defined by the ratio ρ of lymphoid to myeloid cells that HSC generate upon differentiation (which makes ρ a peripheral predictor for the clonal association of a reconstituted hematopoietic system). Balanced HSC repopulate peripheral white blood cells in the same ratio of myeloid to lymphoid cells as seen in unmanipulated mice (on average about 15% myeloid and 85% lymphoid cells, or 3≤ρ≤10). Myeloid-biased (My-bi) HSC give rise to too few lymphocytes resulting in ratios 0<ρ<3, while lymphoid-biased (Ly-bi) HSC generate too few myeloid cells which results in lymphoid-to-myeloid ratios of 10<ρ
Hematopoietic stem cells morphologically resemble lymphocytes. They are non-adherent, rounded, rounded nucleus, and low cytoplasm to nucleus ratio. Since PHSC can not be isolated as a pure population, it is not possible to identify them in a microscope. The above description is based on the morphological characteristics of a heterogeneous population of which PHSC are a component.
Hematopoeitic stem cells are phenotypically identified by their small size, lack of lineage (lin) markers, low staining (side population) with vital dyes such as rhodamine 123 (rhodamineDULL, also called rholo) or Hoechst 33342, and presence of various antigenic markers on their surface many of which belongs to the cluster of differentiation series, like: CD34, CD38, CD90, CD133, CD105, CD45 and also c-kit- the receptor for stem cell factor. The hematopoietic stem cells are negative for the markers which are used for detection of lineage commitment and are thus called Lin-, and during their purification by FACS, a bunch of up to 13 to 14 different mature blood-lineage marker eg CD13 & CD33 for myeloid, CD71 for erythroid, CD19 for B cells, CD61 for megakaryocytic etc for humans; and, B220 (murine CD45) for B cells, Mac-1 (CD11b/CD18) for monocytes, Gr-1 for Granulocytes, Ter119 for erythroid cells, Il7Ra, CD3, CD4, CD5, CD8 for T cells etc for mice) antibodies are used as a mixture to deplete the lin+ cells or late multipotent progenitors (MPP)s.
There are a lot of differences between the human and mice hematopoietic cell markers for the commonly accepted type of hematopoietic stem cells..
However not all stem cells are covered by these combinations which nonetheless have become pupular. In fact even in humans there are hematopoietic stem cells which are CD34-/CD38-. . Also some later studies suggested that earliest stem cells may lack c-kit on the cell surface. For human HSCs use of CD133 was one step ahead as both CD34+ and CD34- HSCs were CD133+.
Traditional purification method used to yield a reasonable purity level of mouse hematopoietic stem cells generally requires a large(~10-12) battery of markers, most of which were surrogate markers with little functional significance and thus partial overlap with the stem cell populations and sometimes other closely related cells which are not stem cells. Also some of these markers 9eg Thy1) are not conserved across mouse species, and use of markers like CD34- for HSC purification requires mice to be at least 8 weeks old. Alternative methods which could give rise to similar or better harvest of stem cells is a hot area of research and are presently emerging. One such method uses a signature of SLAM family of cell surface molecules. SLAM (Signaling lymphocyte activation molecule) family is a group of >10 molecules whose genes are mostly located tandemly in a single locus on chromosome 1 (mouse), all belonging to a subset of immunoglobulin gene superfamily, and originally thought to be involved in T-cell stimulation. This family includes CD48, CD150, CD244 etc, CD150 being the founding member thus also called slamF1 ie SLAM family member 1.
The signature SLAM code for the hemapoietic higherchy are:
For HSCs CD150+CD48- was sufficient instead of CD150+CD48-CD244- because CD48 is a ligand for CD244 and both would be positive only in the activated lineage restricted progenitors. This code was seemingly more efficient than the more tedious earlier set of the large number of markers and are also conserved across the mouse strains; however, recent work has shown this method excludes a large number of HSCs and includes an equally large number of non-stem cells.  . CD150+CD48- gave stem cell purity comparable to Thy1loSca-1+lin-c-kit+ in mice.
Irving Weissman's group at Stanford University that was the first to isolate mouse hematopoietic stem cells in 1988, was also the first to work out the markers to distinguish the mouse long term (LT-HSC) and short term (ST-HSC) hematopoietic stem cells (self renew capable), and the Multipotent progenitors (MPP, low or no self renew capability — the later the developmental stage of MPP, the lesser the self renewal ability and the more of some of the markers like CD4 and CD135):
Nomenclature of hematopoietic colonies and lineages
Between 1948 and 1950, the Committee for Clarification of the Nomenclature of Cells and Diseases of the Blood and Blood-forming Organs issued reports on the nomenclature of blood cells. An overview of the terminology is shown below, from earliest to final stage of development:
The root for CFU-E is "rubri", for CFU-GM is "granulo" or "myelo" and "mono", for CFU-L is "lympho" and for CFU-Me is "megakaryo". According to this terminology, the stages of red blood cell formation would be: rubriblast, prorubricyte, rubricyte, metarubricyte and finally erythrocyte. However, the following nomenclature seems to be, at present, the most prevalent:
Osteoclasts also arise from haemopoietic cells of the monocyte/neutrophil lineage, specifically CFU-GM.
There are various kinds of colony-forming units:
The above CFUs are based on the lineage. Another CFU, the colony-forming unit–spleen (CFU–S) was the basis of an in vivo clonal colony formation, which depends on the ability of infused bone marrow cells to give rise to clones of maturing hematopoietic cells in the spleens of irradiated mice after 8 to 12 days. It was used extensively in early studies, but is now considered to measure more mature progenitor or Transit Amplifying Cells rather than stem cells.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Hematopoietic_stem_cell". A list of authors is available in Wikipedia.|